BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2017 6:39:43 AM | Browse: 1552 | Download: 3420
Publication Name World Journal of Gastroenterology
Manuscript ID 34921
Country Japan
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Basic Study
Article Title Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis
Manuscript Source Unsolicited Manuscript
All Author List Akiharu Kimura, Kyoichi Ogata, Bolag Altan, Takehiko Yokobori, Erito Mochiki, Mitsuhiro Yanai, Norimichi Kogure, Toru Yanoma, Masaki Suzuki, Tuya Bai and Hiroyuki Kuwano
ORCID
Author(s) ORCID Number
Akiharu Kimura http://orcid.org/0000-0002-6832-4146
Kyoichi Ogata http://orcid.org/0000-0001-8059-159X
Bolag Altan http://orcid.org/0000-0002-2222-0966
Takehiko Yokobori http://orcid.org/0000-0003-3284-4796
Erito Mochiki http://orcid.org/0000-0001-5991-4913
Mitsuhiro Yanai http://orcid.org/0000-0002-2627-5665
Norimichi Kogure http://orcid.org/0000-0001-5046-8742
Toru Yanoma http://orcid.org/0000-0003-2513-6521
Masaki Suzuki http://orcid.org/0000-0002-1503-6861
Tuya Bai http://orcid.org/0000-0003-4815-5450
Hiroyuki Kuwano http://orcid.org/0000-0003-1809-8483
Funding Agency and Grant Number
Corresponding Author Akiharu Kimura, MD, PhD, Senior Lecturer, Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan. akimura@gunma-u.ac.jp
Key Words Peritoneal metastasis; Hyperthermia; Hyperthermo-chemotherapy; Heat shock protein 110; Gastric cancer; Drug resistance
Core Tip Gastric cancer remains one of the most common cancers worldwide. Peritoneal dissemination is the most common reason behind gastric cancer (GC) recurrence, and the median survival duration for patients with metastatic and recurrent GC is only 13–16 mo. In our department, we have used intraperitoneal hyperthermo-chemotherapy in patients with advanced rectal cancer and GC with peritoneal metastasis. In this study, we evaluated the significance of heat shock protein 110 (HSP110) expression in GC patients with peritoneal metastasis and assessed the effects of HSP110 suppression on hyperthermo-chemotherapy sensitivity in vitro.
Publish Date 2017-11-12 06:39
Citation Kimura A, Ogata K, Altan B, Yokobori T, Mochiki E, Yanai M, Kogure N, Yanoma T, Suzuki M, Bai T, Kuwano H. Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis. World J Gastroenterol 2017; 23(42): 7541-7550
URL http://www.wjgnet.com/1007-9327/full/v23/i42/7541.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i42.7541
Full Article (PDF) WJG-23-7541.pdf
Full Article (Word) WJG-23-7541.doc